Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial

BACKGROUND: We have conducted a single-arm trial evaluating monthly pentamidine secondary prophylaxis (PSP) to prevent visceral leishmaniasis (VL) relapse in Ethiopian human immunodeficiency virus–infected patients. Outcomes at 12 months of PSP have been previously reported, supporting PSP effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Diro, Ermias, Ritmeijer, Koert, Boelaert, Marleen, Alves, Fabiana, Mohammed, Rezika, Abongomera, Charles, Ravinetto, Raffaella, De Crop, Maaike, Fikre, Helina, Adera, Cherinet, van Loen, Harry, Tsoumanis, Achilleas, Adriaensen, Wim, Hailu, Asrat, van Griensven, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848371/
https://www.ncbi.nlm.nih.gov/pubmed/29020217
http://dx.doi.org/10.1093/cid/cix807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848371/
https://www.ncbi.nlm.nih.gov/pubmed/29020217
http://dx.doi.org/10.1093/cid/cix807

Ejemplares similares